As the whole world already knows, despite the fact that we already have a few viable vaccines against the novel coronavirus, people are still getting severely sick from the new virus.
New drug is a powerful defense against virus complications
More has to be done in this direction. WishTV notes that scientists at Eli Lilly and Company have been investigating one particular drug and they say this is a powerful defence against virus complications. What’s more important, now they have the research to back it up.
The drug is called baricitinib. This drug was originally designed to fight inflammation that is associated with rheumatoid arthritis.
Lilly experts have re-purposed the drug and are using it to combat the inflammation-related complications of COVID-19.
Results to more relevant tests have showed the combination significantly reduced the number of days to hospital discharge compared to the control group.
Experts have discovered the fact that baricitinib can successfully reduce coronavirus-related inflammation without remedesivir.
“Most complications of patients in the hospital are from inflammation.”
This is what Dr. Ana Cardoso, a scientist at Lilly, said.
“Inflammation is driving this virus. It’s what the body does in response [to infection]. That leads to complications and unfortunately deaths. So the motivation behind using baricitinib is [to target] hyperinflammation and reduce disease.”
Coronavirus in the news
Yahoo News notes that Fauci believes that lockdowns the country saw last year are not likely to return, but he warned “things will get worse” during an interview on ABC’s “This Week.”
“I don’t think we’re gonna see lockdowns. I think we have enough of the percentage of people in the country — not enough to crush the outbreak — but I believe enough to not allow us to get into the situation we were in last winter. But things are going to get worse.”
It’s been also reported that there are some crazy data about unvaccinated people and covid 19 out.
You should check out the treatment that the FDA just approved.